InfuSystem (NYSEAMERICAN:INFU) posted its earnings results on Tuesday. The medical instruments supplier reported ($0.05) EPS for the quarter, Morningstar.com reports. The business had revenue of $18.19 million for the quarter.
Shares of InfuSystem stock traded down $0.04 on Wednesday, hitting $4.59. The company had a trading volume of 525 shares, compared to its average volume of 27,823. InfuSystem has a 52 week low of $2.80 and a 52 week high of $5.21.
In related news, Director Scott Shuda acquired 11,224 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The stock was acquired at an average cost of $4.37 per share, for a total transaction of $49,048.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Christopher R. Sansone acquired 25,000 shares of the firm’s stock in a transaction dated Monday, March 18th. The stock was bought at an average price of $4.36 per share, with a total value of $109,000.00. The disclosure for this purchase can be found here. Insiders bought 40,124 shares of company stock valued at $174,507 over the last quarter.
InfuSystem Company Profile
InfuSystem Holdings Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Featured Article: Gap Up Stocks
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.